GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » EV-to-Revenue

Takara Bio (TSE:4974) EV-to-Revenue : 2.04 (As of May. 22, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Takara Bio EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Takara Bio's enterprise value is 円97,046 Mil. Takara Bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円47,670 Mil. Therefore, Takara Bio's EV-to-Revenue for today is 2.04.

The historical rank and industry rank for Takara Bio's EV-to-Revenue or its related term are showing as below:

TSE:4974' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.5   Med: 5.63   Max: 16.94
Current: 2.03

During the past 13 years, the highest EV-to-Revenue of Takara Bio was 16.94. The lowest was 1.50. And the median was 5.63.

TSE:4974's EV-to-Revenue is ranked better than
83.13% of 1043 companies
in the Biotechnology industry
Industry Median: 8.21 vs TSE:4974: 2.03

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Takara Bio's stock price is 円1092.00. Takara Bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円395.88. Therefore, Takara Bio's PS Ratio for today is 2.76.


Takara Bio EV-to-Revenue Historical Data

The historical data trend for Takara Bio's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio EV-to-Revenue Chart

Takara Bio Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.10 7.22 7.22 3.66 2.02

Takara Bio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 2.02 2.09 1.99 2.43

Competitive Comparison of Takara Bio's EV-to-Revenue

For the Biotechnology subindustry, Takara Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takara Bio's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Takara Bio's EV-to-Revenue falls into.



Takara Bio EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Takara Bio's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=97045.835/47670
=2.04

Takara Bio's current Enterprise Value is 円97,046 Mil.
Takara Bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円47,670 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takara Bio  (TSE:4974) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Takara Bio's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1092.00/395.878
=2.76

Takara Bio's share price for today is 円1092.00.
Takara Bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円395.88.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takara Bio EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Takara Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Takara Bio (TSE:4974) Business Description

Traded in Other Exchanges
Address
Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines